Double financing balance
As of March 21, the two financial balances of Shanghai Stock Exchange reported 901426 billion yuan, an increase of 3.653 billion yuan over the previous trading day; The two financial balances of Shenzhen Stock Exchange reported 783658 billion yuan, an increase of 2.097 billion yuan over the previous trading day; The two cities totaled 1685083 billion yuan, an increase of 5.75 billion yuan over the previous trading day.
Latest views
On Monday, the Shanghai composite index was mainly strong in the morning and fluctuated. It fell sharply to 3223 points in the afternoon, and then gradually recovered its lost ground. The Shanghai Composite Index and the gem index rose for four consecutive days. As of the close, the Shanghai stock index rose 0.08%, the Shenzhen Component Index rose 0.41%, the gem index rose 0.46%, the Shanghai and Shenzhen 300 fell 0.17%, the Shanghai Stock Exchange 50 fell 0.72%, and the China Stock Exchange 500 rose 0.42%. The number of gainers in the two cities was 3202, higher than the average value of 2452 last week and lower than 3507 in the previous trading day. The limit was 138, higher than the average of 92 last week and 127 the previous trading day. The number of decliners in the two cities was 1369, lower than the average value of 2221 last week and higher than 1143 in the previous trading day. The number of drop limits was 2, lower than the average value of 44 last week and lower than 3 in the previous trading day. The net outflow of northbound funds was 8.420 billion yuan, with an average net outflow of 3.338 billion yuan last week and a net inflow of 8.457 billion yuan on the previous trading day. The turnover of the two cities was 1016098 billion yuan, with an average value of 1111255 billion yuan last week, compared with 991408 billion yuan the previous trading day. A shares fluctuated strongly, and there is still rebound momentum at present. On Monday, the national Standing Committee rarely focused on the capital market. From last week’s financial committee meeting to today’s national standing committee meeting, the meeting specifications and attention have become higher and higher, which reflects the high attention paid to the capital market and helps to continue to stabilize the risk appetite of floor investors. At present, for the overall judgment of the market, although the China US dollar first meeting last week eliminated the concerns of the “new cold war” between China and the United States to a certain extent and indeed helped to alleviate the market risk appetite, due to the previous continuous rise of a shares, the divergence of funds on the floor, the superposition of the Russian Ukrainian war is still in the white heat stage, and the rebound of international commodity prices, these factors have suppressed the risk appetite of investors, Therefore, we are now entering a process of narrow amplitude oscillation and waiting for a new direction.
Topic tracking
Today’s focus: pig breeding, covid-19 drugs, traditional Chinese Medicine
\u3000\u30001. Pig breeding theme: on February 12, the State Council issued the 14th five year plan for promoting agricultural and rural modernization, which pointed out that the pork production capacity should be stabilized at about 55 million tons and the number of fertile sows should be controlled at about 41 million, no less than 37 million. On February 28, according to the monitoring of the national development and Reform Commission, last week, the national average pig price ratio was 4.98:1, entering the level-1 early warning range of excessive decline determined in the plan for improving the regulation mechanism of government pork reserves and ensuring supply and stable price in the pork market. On March 15, the national development and Reform Commission said that it would start the collection and storage of the third batch of central frozen pork reserves with relevant departments this year and guide all localities to speed up the collection and storage. On March 18, the notice on further improving the work related to important Shenzhen Agricultural Products Group Co.Ltd(000061) production such as grain and soybeans, published on the official website of the national development and Reform Commission, proposed that we should pay close attention to the study and judgment of the supply and demand situation of pigs and the evolution of pig cycle in this region, timely take targeted measures such as government collection and storage, stabilize the long-term support policy for pig production, stabilize the basic production capacity and prevent the ups and downs of production. Suggested attention: Fujian Aonong Biological Technology Group Incorporation Limited(603363) ( Fujian Aonong Biological Technology Group Incorporation Limited(603363) ), Tech-Bank Food Co.Ltd(002124) ( Tech-Bank Food Co.Ltd(002124) )
\u3000\u30002. Covid-19 drug subject: on February 11, 2022, according to the relevant provisions of the drug administration law, the State Drug Administration (nmpa) approved the import registration of Pfizer’s anti sars-cov-2 therapeutic drug nimatovir tablets / ritonavir tablets combination packaging (paxlovid) with conditions. It fully shows the state’s attitude and demand for oral drugs as epidemic prevention and control. On March 19, China Meheco Group Co.Ltd(600056) officials said that paxlovid, the first covid-19 virus treatment drug China Meheco Group Co.Ltd(600056) cooperated with Pfizer, was transported to China Meheco Group Co.Ltd(600056) Daxing logistics center, and all goods were transported through closed-loop management of the whole process and completed acceptance and warehousing in accordance with the epidemic prevention requirements related to import and export. Suggestions: Chengda Pharmaceutical (301201), Jinghua Pharmaceutical Group Co.Ltd(002349) ( Jinghua Pharmaceutical Group Co.Ltd(002349) )
\u3000\u30003. Theme of traditional Chinese medicine: it is mentioned in the government work report of the State Council in 2022 to support the revitalization and development of traditional Chinese medicine and promote the comprehensive reform of traditional Chinese medicine. In February 2022, the Information Office of the State Council held a policy briefing, which clearly proposed to persevere and jointly promote the “three medical linkage”, promote the normalization reform of the centralized procurement of drugs and consumables organized by the state, and put forward that the scope of centralized procurement of Chinese patent medicines should be further expanded. On March 2, 15 departments including the National Health Commission, the Ministry of education and the State Administration of traditional Chinese medicine jointly issued the “14th five year plan for healthy aging”, which proposed to develop traditional Chinese medicine health services for the elderly. The epidemic is not over yet. The government proposes to continue to do a good job in normalized epidemic prevention and control and give better play to the role of traditional Chinese medicine. Suggested attention: Hunan Er-Kang Pharmaceutical Co.Ltd(300267) ( Hunan Er-Kang Pharmaceutical Co.Ltd(300267) ), Tianjin Chase Sun Pharmaceutical Co.Ltd(300026) ( Tianjin Chase Sun Pharmaceutical Co.Ltd(300026) )
Risk tips
The epidemic has not been effectively controlled, the macro economy has unexpectedly declined, the liquidity crunch has intensified, and the industrial policies are lower than expected.
